Get the Stockscreener App
11.47
0.70%
0.08
After Hours:
11.47
Certara Inc stock is traded at $11.47, with a volume of 1.26M.
It is up +0.70% in the last 24 hours and down -8.31% over the past month.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.
See More
Previous Close:
$11.39
Open:
$11.44
24h Volume:
1.26M
Relative Volume:
1.54
Market Cap:
$1.85B
Revenue:
$360.69M
Net Income/Loss:
$-61.40M
P/E Ratio:
95.58
EPS:
0.12
Net Cash Flow:
$60.93M
1W Performance:
-6.37%
1M Performance:
-8.31%
6M Performance:
-40.75%
1Y Performance:
-22.50%
1-Day Range:
$10.92
$11.58
1-Week Range:
$10.92
$12.37
52-Week Range:
$10.92
$19.87
Certara Inc Stock (CERT) Company Profile
Name
Certara Inc
Sector
Industry
Phone
(415) 237-8272
Address
4 RADNOR CORPORATE CENTER, SUITE 350, RADNOR
Certara Inc Stock (CERT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-10-24 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-04-24 | Initiated | JMP Securities | Mkt Perform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-07-23 | Initiated | UBS | Neutral |
| Dec-05-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Aug-22-23 | Downgrade | Jefferies | Buy → Hold |
| Aug-10-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Apr-03-23 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Sep-08-22 | Initiated | Berenberg | Buy |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jul-01-22 | Initiated | Piper Sandler | Overweight |
| Jan-11-22 | Upgrade | Jefferies | Hold → Buy |
| Aug-05-21 | Resumed | Credit Suisse | Neutral |
| Jul-23-21 | Initiated | Robert W. Baird | Outperform |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-06-21 | Initiated | Morgan Stanley | Equal-Weight |
| Jan-05-21 | Initiated | BofA Securities | Buy |
| Jan-05-21 | Initiated | Credit Suisse | Neutral |
| Jan-05-21 | Initiated | Jefferies | Hold |
| Jan-05-21 | Initiated | William Blair | Outperform |
View All
Certara Inc Stock (CERT) Latest News
Certara (NASDAQ:CERT) Hits New 52-Week Low at $10.96 - MarketBeat
A look into Certara Inc (CERT)’s deeper side - SETE News
Certara Inc Inc. (CERT) Price Performance: A Technical Analysis Perspective - The InvestChronicle
Computational Toxicology Software Market Show Incredible Growth Soon | Certara, BIOVIA, Zymergen - openPR
The Certara Inc (CERT) had a good session last reading, didn’t it? - US Post News
Financial Snapshot: Analyzing Certara Inc (CERT)’s Key Ratio Metrics - The Dwinnex
Certara (NASDAQ:CERT) Sees Unusually-High Trading Volume - MarketBeat
Certara (NASDAQ:CERT) Sets New 52-Week Low at $11.69 - MarketBeat
Certara stock hits 52-week low at $11.69 amid market challenges - Investing.com
Certara Inc (CERT) looking to reclaim success with recent performance - SETE News
CERTCertara, Inc. Latest Stock News & Market Updates - StockTitan
Certara, Inc. (NASDAQ:CERT) Short Interest Up 11.2% in August - MarketBeat
Certara, Inc. (NASDAQ:CERT) Shares Could Be 35% Above Their Intrinsic Value Estimate - Simply Wall St
Should You Think About Buying Certara, Inc. (NASDAQ:CERT) Now? - Yahoo Finance
Certara Inc [CERT] Shares Fall Approximately -25.15% Over the Year - Knox Daily
Certara, Inc. (CERT): Among The Best Medical AI Companies - MSN
Post-Trade Analysis: Certara Inc (CERT) Slides -5.24, Closing at 12.47 - The Dwinnex
Are Certara Inc (CERT) shares a good deal now? - US Post News
CERT’s Stock Market Adventure: -29.11% YTD Growth Amidst Volatility - The InvestChronicle
(CERT) On The My Stocks Page - Stock Traders Daily
Certara, Inc. (CERT): Among The Best Medical AI Companies - Yahoo Finance
Brokerages Set Certara, Inc. (NASDAQ:CERT) Price Target at $17.79 - MarketBeat
Certara (NASDAQ:CERT) Releases FY 2024 Earnings Guidance - MarketBeat
Ready to Jump After Recent Trade: Certara Inc (CERT) - SETE News
Head to Head Survey: Freshworks (NASDAQ:FRSH) versus Certara (NASDAQ:CERT) - Defense World
Certara, Inc. (NASDAQ:CERT) Shares Sold by Baillie Gifford & Co. - MarketBeat
SG Americas Securities LLC Takes $226,000 Position in Certara, Inc. (NASDAQ:CERT) - Defense World
Certara to Participate in Upcoming Investor Conferences - GlobeNewswire
Certara to Participate in Upcoming Investor Conferences - Yahoo Finance
Certara to Participate in Upcoming Investor Conferences - StockTitan
Certara Inc (CERT) Stock: Navigating a Year of Volatility - The InvestChronicle
Certara Inc (CERT) deserves closer scrutiny - US Post News
Certara (NASDAQ:CERT) Shares Up 2.3% - MarketBeat
CERT (Certara) GF Value Rank : 8 (As of Aug. 19, 2024) - GuruFocus.com
Certara (MEX:CERT) 3-Year Dividend Growth Rate : 0.00% (As of Jun. 2024) - GuruFocus.com
What is Certara Inc (CERT) Stock Return on Shareholders’ Capital? - SETE News
Certara (MEX:CERT) Debt-to-EBITDA : 7.77 (As of Jun. 2024) - GuruFocus.com
Certara (MEX:CERT) Cash Flow from Investing : MXN-1,278 Mil (TTM As of Jun. 2024) - GuruFocus.com
Certara (MEX:CERT) 3-Year EBITDA Growth Rate : 3.80% (As of Jun. 2024) - GuruFocus.com
Certara (MEX:CERT) Earnings per Share (Diluted) : MXN-8.72 (TTM As of Jun. 2024) - GuruFocus.com
Certara (MEX:CERT) Total Inventories : MXN0 Mil (As of Jun. 2024) - GuruFocus.com
Certara (MEX:CERT) Volatility : N/A% (As of Aug. 18, 2024) - GuruFocus.com
Certara (MEX:CERT) Future 3-5Y EPS without NRI Growth Rate : 10.85 (As of Aug. 18, 2024) - GuruFocus.com
Certara (MEX:CERT) 3-Year EPS without NRI Growth Rate : 9.20% (As of Jun. 2024) - GuruFocus.com
Certara (MEX:CERT) Days Inventory : 0.00 (As of Jun. 2024) - GuruFocus.com
Certara launches new Phoenix software version to boost drug development - Investing.com
Certara launches new Phoenix software version to boost drug development By Investing.com - Investing.com UK
Certara Launches Phoenix™ Version 8.5 Drug Development Software - GlobeNewswire
Certara Launches Phoenix™ Version 8.5 Drug Development Software - StockTitan
Certara Inc (CERT) Stock: A Year of Stock Market Dynamics - The InvestChronicle
Certara stock hits 52-week low at $11.81 amid market challenges - Investing.com
Certara Inc Stock (CERT) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.30%
0.82%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):